Feb. 13, 2024 Price forecast | 2 weeks: -0.64% | 1 month: -1.29% | 3 months: -2.45%


NBIX stock forecast

Our latest prediction for Neurocrine Biosciences, Inc.'s stock price was made on the Feb. 13, 2024 when the stock price was at 133.84$.

In the short term (2weeks), NBIX's stock price should underperform the market by -0.64%. During that period the price should oscillate between -7.63% and +2.38%.

In the medium term (3months), NBIX's stock price should underperform the market by -2.45%. During that period the price should oscillate between -27.84% and +-2.69%.

Create a solid portfolio with NBIX

Add NBIX to your portfolio and optimize it!


About Neurocrine Biosciences, Inc.

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

At the moment the company generates 71M USD in revenues.

On its last earning announcement, the company reported a profit of 2.56$ per share.

The book value per share is 4.17$

Neurocrine Biosciences, Inc. website


Three months stock forecastFeb. 13, 2024


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
71M - 250M - 249M 2.56 - - 98M 4.17 - - -